REVIEW PAPER
Allergenic potential of moulds isolated from buildings
 
More details
Hide details
1
Department of Allergology and Environmental Hazards, Institute of Rural Health, Lublin, Poland
2
University of Life Science in Lublin, Poland
 
Ann Agric Environ Med. 2013;20(3):500–503
KEYWORDS:
ABSTRACT:
Introduction:
Moulds are the one of the known biological factors that have a negative impact on human health. Moulds are commonly present in residential and work environments. Materials plentiful in organic compounds, such as building materials or paints, are a splendid substrate for the development of moulds. The first documented mention of a study describing the harmful effects caused by moulds in buildings emerged in the early nineteenth century. In Copenhagen and then in Padua, moulds of the genus Penicillium, Cladosporium and Mucor were found in buildings.

Objective:
To present the current state of the allergic properties and other negative health effects caused by moulds isolated from buildings.

Brief description of the state of knowledge:
The literature and own research clearly shows that moulds and their secondary metabolites can evoke toxic effects on human and animal health, and cause symptoms similar to allergic diseases. These allergens have been noted in spores as well as other fungal fragments; however, most allergens are located in germinating spores, in the hyphal tips and in mycelia. Fungal allergy can express in different ways: asthma, rhinitis, conjunctivitis, urticaria and atopic dermatitis. Fungal allergy antigen is bound to IgE-dependent reactions but also to reactions independent of IgE.

Conclusions:
Moulds are a significant but difficult to detect etiologic agent of different allergic diseases. Prevention of this diseases is important for patients with suspected connection between common allergic symptoms and affinity with moulds.

CORRESPONDING AUTHOR:
Wioletta Żukiewicz-Sobczak   
Department of Allergology and Environmental Hazards, Institute of Rural Health, Lublin, Poland
 
REFERENCES (45):
1. Zyska B. Biological hazards in the building. Arkady 1999.
2. Piotrowska M, Żakowska Z, Gliścińska A, Bogusławska-Kozłowska J. The role of outdoor air microflora in the development indoor fungal bioaerosol. II Conference „Decomposition and microbiological corrosion technical materials”, 30–31 May, 2001, Politechnika Łódzka, Łódź.
3. Helbling A, Reimers A. Immunotherapy in fungal allergy. Curr. Allergy Asthma Rep. 2003; 3: 447–453.
4. Krajewska-Kułak E, Łukaszuk C. Fungal infections in the human environment. In: Baran E. Mycology – what’s new? Cornetis, Wrocław, 2008.
5. Wiszniewska M, Walusiak J, Gutarowska B, Żakowska Z, Pałczyński C. Mold in the communal environment and the workplace – a significant health risk. Med Pr. 2004; 55(3): 257–266.
6. Mniszek W, Rogiński J. Construction faults the cause mold building accommodation. http://studia.wszop.edu.pl/obr... (access: 2012.11.22).
7. Bousquet J, Cauwenberge P. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001; 108: 162–167.
8. Platts-Mills TA, Hayden ML, Chapman MD, Wilkins SR. Seasonal variation in dust mite and grass-pollen allergens in dust from the housesof patients with asthma. J Allergy Clin Immunol. 1987; 79: 781–791.
9. Lacey J. Fungi and Actinomycetes as allergen. In: Kay A.B. Allergy and allergic diseases. Blackwell Science, London 1997.
10. Bush R, Portnoy J. The role and abatement of fungal allergens in allergic diseases. J. Allergy Clin Immunol. 2001; 107: 430–440.
11. Cakmak S, Dales RE, Burnett RT, Judek S, Coates F, Brook JR. Effect of airborne allergens on emergency visits by children for conjunctivitis and rhinitis. Lancet 2002; 359(9310): 947–8.
12. Hussein HS, Brasel JM. Toxicity, metabolism, and impact of mycotoxins on humans and animals. Toxicology 2001; 167: 101–134.
13. Dutkiewicz J, Górny RL. Biological factors hazardous to human health: classification and criteria of exposure assessment. Med Pr. 2002; 53(1): 29–39.
14. Nabrdalik M, Latała A. Moulds in buildings. Roczn. PZH, 2003; 54(1): 119–128.
15. Piontek M. Molds and mycological risk assessment in residential buildings. Oficyna Wydawnicza Uniwersytetu Zielonogórskiego, Zielona Góra 2004.
16. Ejdys E. Effect of atmospheric air on the quality of bioaerosol of school facilities in the spring and autumn season – mycological evaluation. Ochrona Środowiska Zasobów Naturalnych, 2009; 41: 142–150.
17. Grajewski J, Twarużek M. The healthy aspects of the influence of moulds and mycotoxins. http://www.alergia.org.pl/leka... (access: 2012.11.23).
18. Gutarowska B. Destruction of technical materials by microorganisms. http://www.cbr.edu.pl/fnr/nisz... (access: 2012.11.23).
19. Krajewska-Kułak E, Gniadek A, Kantor A, Macura AB. Analysis of incidence of pathogenic fungi in air at the department of chronic care. Preliminary study. Mikol Lek. 2010; 17: 21–29.
20. Krzysztofik B. Microbiology air. Wydawnictwo Politechniki Warszawskiej, Warszawa 1992.
21. Krajewska-Kułak E, Łukaszczuk C, Oksiejczuk E, Gniadek A, Macura AB, Lewko J, et al. Indoor air studies of fungi contamination of social welfare homes in Białystok and the surrounding area during summer and autumn. Mikol Lek. 2002; 9: 59–66.
22. Gładysz J, Grzesiak A, Nieradko-Iwanicka B, Borzęcki A. The influence of air pollution on human health and life expectancy. Probl Hig Epidemiol. 2010; 91: 178–180.
23. Etzel R, Rylander R. Indoor mold and children’s health. Environ Health Perspect. 1999; 3: 463.
24. Miklaszewska B, Grajewski J. Pathogenic and allergic moulds in human environment. Alergia 2005; 2(24): 45–50.
25. Singh J. Dry rot and other wood-destroying fungi: their occurrence, biology, pathology and control. Indoor and Built Environ. 1999; 8: 3–20.
26. World Health Organization (WHO) Guidelines for Indoor Air Quality: dampness and mould. http://www.euro.who.int/data/a... (access: 2012.11.22).
27. Reynolds SJ, Black DW, Borin SS, Breuer G, Burmeister LF, Fuortes LJ et al. Indoor Environmental Quality in Six Commercial Office Buildings in the Midwest United States. Appl Occup Environ Hyg. 2001; 16(11): 1065–1077.
28. Buczyńska A, Cyprowski M, Piotrowska M, Szadkowska-Stańczyk I. Indoor moulds: results of the environmental study in office rooms. Med Pr. 2007; 58: 521–525.
29. Green BJ, Sercombe JK, Tovey, ER. Fungal fragments and undocumented conidia function as new aeroallergen sources. J Allergy Clin Immun. 2005; 115(5): 1043–1048.
30. Mitakakis TZ, Barnes C, Tovey ER. Spore germination increases allergen release from Alternaria. J Allergy Clin Immun. 2001; 107(2): 388–390.
31. Green BJ, Mitakakis TZ, Tovey ER. Allergen detection from 11 fungal species before and after germination. J Allergy Clin Immun. 2003; 111(2): 285–289.
32. NAS. Clearing the Air. Asthma and Indoor Air Exposures. Committee on Assessment of Asthma and Indoor Air. Institute of Medicine, Division of Health Promotion and Disease Prevention. National Academy Press, Washington, D.C. 2000, p. 438.
33. Jahnz-Różyk K. Introduction to moulds allergy. Pol. Merk Lek., 2008; 24(S1): 7–10.
34. Galęba A, Zawirska A, Adamski Z. Allergic diseases and their correlation with fungi. Mikologia Lek. 2007; 14(4): 271–275.
35. Leser Ch, Kauffman H, Virchow Ch, Menz G. Specific serum immunopatterns in clinical phases of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 1992; 90: 589–599.
36. Usowska A, Rapiejko P. Allergic conjunctivitis. Terapia, 2001; 1: 12–23.
37. Kuna P. Bronchial asthma – epidemiology, pathophysiology, clinic. Przew Lek. 2002; 5(4): 22–31.
38. Dutkiewicz J, Skórska C, Mackiewicz B, Cholewa G. Prevention of diseases due to organic dust in agriculture and food industry. Instytut Medycyny Wsi, 2000.
39. Baran E. Zarys mikologii lekarskiej. Volumed, Wrocław, 1998.
40. Brooks St. Host susceptibility to indoor air pollution. J Allergy Clin Immunol. 1994; 94: 334–351.
41. Hammad Y. The problem of the „sick” building – facts and implications. Identifying and measuring indoor nonbiologic agents. J Allergy Clin Immunol. 1994; 94: 296–303.
42. Kędzierska I, Kędzierski W, Kurzawa R. Wpływ zmienionych warunków środowiskowych na powstawanie i rozwój chorób alergicznych. Effect of modified environmental conditions on the formation and development of allergic diseases. Terapia, 1996; 5: 3–14.
43. Ochmański W. Barabasz W. Mikrobiologiczne zagrożenia budynków i pomieszczeń mieszkalnych oraz ich wpływ na zdrowie (syndrom chorego budynku). Microbiological hazards of residential buildings and their impact on health (sick building syndrome). Przegl Lek. 2000; 7–8: 419–423.
44. Wittczak T, Walusia J, Paczyński C. Sick building syndrome – nowy problem w medycynie pracy. Sick building syndrome – a new problem in occupational medicine. Med Pr. 2001; 5: 369–373.
45. Haverinen-Shaughnessy U. Prevalence of dampness and mold in European housing stock. J Expo Sci Environ Epidemiol. 2012; 22(5): 461–7. doi: 10.1038/jes.2012.21. (access: 2013.01.19) Erratum in J Expo Sci Environ Epidemiol. 2012; 22(6): 654.
eISSN:1898-2263
ISSN:1232-1966